, Columnist
Dying to Survive, China Shows the Way on Drug Prices
If Trump thinks he did well with Pfizer, he should look across the Pacific.
They said how much?
Photographer: Kevin Lee/Bloomberg
This article is for subscribers only.
U.S. President Donald Trump exulted this week over Pfizer Inc.’s decision to delay planned drug price increases a day after he attacked the company on Twitter. He should take a look at China, where President Xi Jinping has done much better.
Over the past two weeks, the U.S. pharmaceutical giant quietly cut the prices of more than a dozen of its medications in China by as much as 10 percent.